INS and Alzheimer disease: De la Monte et al. have suggested that energy metabolism, glucose utilization, and insulin sensitization are compromised in Alzheimer’s disease (AD) patients, whereas these pathological symptoms may contribute to AD neuropathology [13,14,15,16].